On the contrary, the inhibition of S1PR2 by JTE-013 or the knockdown of S1pr2 by S1pr2-shRNA resulted in reduced tumor cell migration and invasion compared to control PSCs. This evidence concerns the gene S1PR2 and neoplasm.